-
GSK takes smoking cessation to a new level with mini lozenge
PARSIPPANY, N.J. GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking-cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market. The lozenges will be lined-priced with existing smoking-cessation products and will be sold at U.S. retail healthcare centers as three small vials, each containing 27 lozenges.